Literature DB >> 1972873

Vecuronium dose-response and maintenance requirements in patients with myasthenia gravis.

E Nilsson1, O A Meretoja.   

Abstract

Eleven myasthenia gravis and seven control patients were studied during N2O/O2-fentanyl anesthesia to determine the ED50, ED95, and maintenance requirement of vecuronium using both mechanomyography and electromyography. The ED95 of vecuronium was 17 (range 8-34) micrograms/kg in patients with myasthenia gravis, and this was significantly related to patient's acetylcholine receptor antibody titer (r = -0.75, P less than 0.01). The average ED95 value was 250% greater in control than in myasthenic patients (P less than 0.01). The hourly requirement of vecuronium to maintain an 80-90% neuromuscular blockade was 38 +/- 10 micrograms/kg in myasthenic and 120 +/- 27 micrograms/kg in control patients (P less than 0.001). When these requirements were related to individual ED95 doses, they were comparable indicating similar time durations of effect of vecuronium following an equipotent dose in myasthenic and in control patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1972873     DOI: 10.1097/00000542-199007000-00005

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  3 in total

Review 1.  Airway management in neurological emergencies.

Authors:  Lynn P Roppolo; Karina Walters
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

2.  Neuromuscular effects of sevoflurane in patients with myasthenia gravis.

Authors:  T Morita; H Tsukagoshi; D Kurosaki; T Sugaya; D Yoshikawa; H Shimada
Journal:  J Anesth       Date:  1996-09       Impact factor: 2.078

3.  Succinylcholine and vecuronium blockade of the diaphragm, laryngeal and limb muscles in the anaesthetized goat.

Authors:  C Ibebunjo; L W Hall
Journal:  Can J Anaesth       Date:  1994-01       Impact factor: 5.063

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.